{"protocolSection":{"identificationModule":{"nctId":"NCT03604081","orgStudyIdInfo":{"id":"17-00773"},"organization":{"fullName":"NYU Langone Health","class":"OTHER"},"briefTitle":"Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task Practice","officialTitle":"Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task Practice, 7 Times Per Week for 2 Weeks."},"statusModule":{"statusVerifiedDate":"2020-08","overallStatus":"WITHDRAWN","whyStopped":"PI has encountered recruitment challenges.","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2018-06-11","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2020-08-14","type":"ACTUAL"},"completionDateStruct":{"date":"2020-08-14","type":"ACTUAL"},"studyFirstSubmitDate":"2018-07-18","studyFirstSubmitQcDate":"2018-07-18","studyFirstPostDateStruct":{"date":"2018-07-27","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-08-31","lastUpdatePostDateStruct":{"date":"2020-09-02","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"NYU Langone Health","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This is a prospective randomized control trial of patients with unilateral impairment of the lower extremity after stroke. Patients will be randomized to intervention group and control group. Intervention group will receive one hour of intense massed practice of lower extremity either in the form of shaping or task practice. Control group will receive conventional physical therapy for 1 hour as per current standard of care that follows stroke clinical practice guideline."},"conditionsModule":{"conditions":["Stroke"],"keywords":["Constraint Induced Movement Therapy"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":0,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Intervention Group","type":"EXPERIMENTAL","description":"One hour of intense massed practice of lower extremity either in the form of shaping or task practice","interventionNames":["Other: CIMT"]},{"label":"Control Group","type":"PLACEBO_COMPARATOR","description":"Conventional physical therapy for 1 hour as per current standard of care that follows stroke clinical practice guideline.","interventionNames":["Other: Conventional Physical Therapy"]}],"interventions":[{"type":"OTHER","name":"CIMT","description":"Intervention group will receive one hour of intense massed practice of lower extremity either in the form of shaping or task practice.","armGroupLabels":["Intervention Group"]},{"type":"OTHER","name":"Conventional Physical Therapy","description":"1 hour as per current standard of care that follows stroke clinical practice guideline.","armGroupLabels":["Control Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Cycle time as measured by GAITRite.","description":"GAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.","timeFrame":"2 Weeks"},{"measure":"step length as measured by GAITRite.","description":"GAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.","timeFrame":"2 Weeks"},{"measure":"Stride length as measured by GAITRite.","description":"GAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.","timeFrame":"2 Weeks"},{"measure":"velocity as measured by GAITRite","description":"GAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.","timeFrame":"2 Weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 55 or older\n* new ischemic stroke as revealed by CT scan or MRI of a brain or as per updated definition by American heart and American stroke association (Sacco et al., 2013)\n* Manual muscle testing with grad of \\> 1+ in hip and knee joint musculature\n* able to walk atleast 10 feet indoors with or without assistance and assistive device.\n* Motivated to participate and some initiation of flexion and extension movement in hip, knee and ankle joints.\n* Ability to follow visual/verbal instructions as assessed by a minimum score of 24/30 points on the minimental state examination\n* Fairly intact sensation\n\nExclusion Criteria:\n\n* Serious cardiac or pulmonary condition or other medical condition that make it difficult or risky to participate in intensive training\n* Severe joint pain or degenerative disease to the musculoskeletal system of the lower extremity\n* other neurological disease 4) problems with following instructions.","healthyVolunteers":false,"sex":"ALL","minimumAge":"55 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Nada Abou-Fayssal, MD","affiliation":"NYU Langone Health","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"New York University School of Medicine","city":"New York","state":"New York","zip":"10016","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}